Skip to content

Tegafur-gimeracil-oteracil potassium (TS-1)

DRUG2 trials

Sponsors

Hokuriku-Kinki Immunochemotherapy Study Group, Tokyo Metropolitan Oncology Group

Conditions

Gastric Cancer

Related Papers